Adam E. Logal
Senior VP, CFO, Chief Accounting Officer & TreasurerMr. Adam E. Logal has been the Chief Financial Officer and Senior Vice President of Opko Health, Inc. since March 2014 and also serves as Chief Accounting Officer and Treasurer from July 2012. He serves as Director at Non-Invasive Monitoring Systems, Inc. since September 3, 2025. He served Vice President of Finance of Opko Health, Inc. from July 2012 until March 2014 and Director of Finance from March 2007 to July 2012. Mr. Logal also served as President of GeneDx, LLC from July 2020 to June 2021. Mr. Logal has experience in the biopharmaceuticals industry. He is a strategic finance executive with extensive experience in SEC compliance and reporting, domestic and international finance, strategic planning, cash flow management, budgeting, taxation, treasury and business development. He served as Secretary at Opko Health, Inc. since March 27, 2007. He served as the Chief Accounting Officer and Executive Director of Finance of Acuity Pharmaceuticals, Inc. He served as the Chief Accounting Officer, Executive Director of Finance, Secretary and Treasurer at eXegenics Inc. He served as an Interim Chief Financial Officer, Chief Accounting Officer and Treasurer of Nabi Biopharmaceuticals Inc. since March 6, 2006. He served as Director for Accounting and Reporting at Nabi Biopharmaceuticals since April 2005 and its Senior Director of Accounting and Reporting. From June 2003 to April 2005, he served in various roles in Nabi Biopharmaceutical's external reporting group, Senior Manager, External Reporting and Taxation and from November 2002 to June 2003 its Accountant in its manufacturing group. He previously served on the board of directors of Xenetics Biosciences, Inc. from 2017 to 2024. He served as a Tax Accountant of Spherion Corporation from May 2001 to November 2002. From November 2000 to May 2001, he served as Staff Accountant for Dunn & Co., CPAs PA. Mr. Logal served as the Chairman of the Board of Xenetic Biosciences, Inc. until November 08, 2024 and served as its Independent Director since August 14, 2017 until November 08, 2024. Mr. Logal served an Independent Director at VBI Vaccines Inc. (SciVac Therapeutics Inc.) since April 2014 until October 17, 2018. He was Bio-Reference Laboratories Inc. since August 20, 2015 until 2018.
Positions
- Company NameOPKO Health, Inc.Stock CodeOPKPositionSenior VP, CFO, Chief Accounting Officer & Treasurer
